viernes, 30 de noviembre de 2018

Cervical Cancer Treatment (PDQ®)—Health Professional Version - National Cancer Institute

Cervical Cancer Treatment (PDQ®)—Health Professional Version - National Cancer Institute

Cervical Cancer Treatment (PDQ®)—Patient Version - National Cancer Institute

Cáncer de cuello uterino (PDQ®)—Versión para pacientes - National Cancer Institute

Cáncer de cuello uterino (PDQ®)—Versión para profesionales de salud - National Cancer Institute



National Cancer Institute





Cervical Cancer Treatment (PDQ®)–Health Professional Version

Changes to This Summary (11/14/2018)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Revised text to state palliative chemotherapy and other systemic therapy as standard treatment options for Stage IVB and recurrent cervical cancer.
Revised text to include palliative chemotherapy and other systemic therapy as standard treatment options for stage IVB cervical cancer.
Added text to state that with the exception of immunotherapy, which has provided prolonged disease-free survival, other options are unlikely to result in curative outcomes and are mostly applied for palliative purposes.
Added text to include palliative chemotherapy and other systemic therapy as a treatment option for recurrent cervical cancer.
Added Immunotherapy as a new subsection.
This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
  • Updated: November 14, 2018

No hay comentarios:

Publicar un comentario